Safety and tolerability of extended-release venlafaxine in severe medical and surgical illness.
This study attempted to determine if extended-release venlafaxine is safe for use in severely medically and surgically ill depressed patients. The charts of 16 patients who were admitted to medical and surgical inpatient services and given extended-release venlafaxine were retrospectively evaluated for dose and duration of drug treatment, blood pressure changes, medication changes, and side effects. There was 50%-75% improvement in depressive symptoms, with a statistically insignificant mean elevation in blood pressure. Extended-release venlafaxine appears to be a safe and tolerable agent for the medical-surgical depressed inpatient.